Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
values decrease » values increased (Expand Search)
rate increased » greater increase (Expand Search)
alt rate » daly rate (Expand Search), call rate (Expand Search), alt ratio (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
values decrease » values increased (Expand Search)
rate increased » greater increase (Expand Search)
alt rate » daly rate (Expand Search), call rate (Expand Search), alt ratio (Expand Search)
-
161
Supplementary file 1_The role of micro-CT in breast cancer management: a systematic review on the clinical applications of micro-CT in breast cancer and a diagnostic accuracy meta-...
Published 2025“…Micro-computed tomography (micro-CT) has already exhibited clinical value, yielding high-resolution three-dimensional (3D) volumetric images. …”
-
162
Impact of COVID-19 on the volume of emergency CT studies in a neuro-trauma reference center
Published 2021“…There was a decrease (p value 0.002) in the number of brain-CTs, from 664 in weeks 1-6, to 303 in weeks 7-12. …”
-
163
-
164
-
165
<sup>68</sup>Ga-Galmydar: A PET imaging tracer for noninvasive detection of Doxorubicin-induced cardiotoxicity
Published 2019“…</p><p>Methods and results</p><p>To assess <sup>68</sup>Ga-Galmydar ability for monitoring DOX-induced cardiomyopathy, microPET imaging was performed 5 d post treatment of rats either with a single dose of DOX (15 mg/kg) or vehicle as a control (saline) and images were co-registered for anatomical reference using CT. Following tail-vein injection of the radiotracer in rats at 60 min, micro-PET/CT static scan (10 min acquisition), <sup>68</sup>Ga-Galmydar demonstrated 1.91-fold lower uptake in hearts of DOX-treated (standard uptake value; SUV: 0.92, n = 3) rats compared with their vehicle treated (SUV: 1.76, n = 3) control counterparts. …”
-
166
Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy
Published 2023“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. Mechanistic analyses revealed that the drug induced immunogenic cell death and restored tumor immune microenvironment toward tumor clearance in vivo, resulting in a great decrease in tumor-infiltrating Tregs and an increase in the CD8<sup>+</sup> T/Treg ratio when combined with anti-PD-1. …”
-
167
Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy
Published 2023“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. Mechanistic analyses revealed that the drug induced immunogenic cell death and restored tumor immune microenvironment toward tumor clearance in vivo, resulting in a great decrease in tumor-infiltrating Tregs and an increase in the CD8<sup>+</sup> T/Treg ratio when combined with anti-PD-1. …”
-
168
Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy
Published 2023“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. Mechanistic analyses revealed that the drug induced immunogenic cell death and restored tumor immune microenvironment toward tumor clearance in vivo, resulting in a great decrease in tumor-infiltrating Tregs and an increase in the CD8<sup>+</sup> T/Treg ratio when combined with anti-PD-1. …”
-
169
Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy
Published 2023“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. Mechanistic analyses revealed that the drug induced immunogenic cell death and restored tumor immune microenvironment toward tumor clearance in vivo, resulting in a great decrease in tumor-infiltrating Tregs and an increase in the CD8<sup>+</sup> T/Treg ratio when combined with anti-PD-1. …”
-
170
-
171
-
172
-
173
Confusion matrices of (a-b) 60:40 of TRAP/TESP and (c-d) 70:30 of TRAP/TESP.
Published 2025Subjects: -
174
-
175
-
176
-
177
-
178
-
179
-
180